Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
8.9 USD | -0.34% | +14.10% | +52.66% |
May. 13 | Janney Starts TScan Therapeutics With Buy Rating, $11 Price Target | MT |
May. 13 | TScan Therapeutics, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+52.66% | 509M | |
+33.37% | 50.85B | |
+1.55% | 42.82B | |
+49.00% | 42.03B | |
-4.22% | 29.55B | |
+11.57% | 26.11B | |
-21.00% | 19.13B | |
+7.36% | 13.05B | |
+28.30% | 12.16B | |
+23.80% | 12.08B |
- Stock Market
- Equities
- TCRX Stock
- News TScan Therapeutics, Inc.
- Barclays Raises Price Target on TScan Therapeutics to $9 From $7, Keeps Overweight Rating